Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Post by sunny3999on Jan 23, 2018 1:16am

389 Views

Post# 27413559

Time has come: If Aphria Partner Tetra Bio Pharma.....

.....shows positive results with PPP01, Aphria wins as well because Princeps Rx is launched with Aphria because GMP Q certification with Aphria was not the beginning but this news!

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

16 November, 2017

... and I think the time has come and is overdue: PPP001 should have positive results, from which I expect and take a look at the pipeline, with now a total of 5 new drugs, which together addresses a double-digit billion market, Tetra Bio Pharma is on the verge of doubling or multiplying! (Just my 2 cents!)

Sources:
Tetra Bio Pharma Pipeline:

Tetra Bio Pharma presentation:

image: https://assets.wallstreet-online.de/_media/2503/board/20180123060114-tetra-bio-pharma-pipeline.jpg